Synaptic degeneration in Alzheimer’s disease

[1]  Michael T. Lin,et al.  Co-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses , 2010, Neurobiology of Aging.

[2]  S. Rohn,et al.  FAD-mutation of APP is associated with a loss of its synaptotrophic activity , 2009, Neurobiology of Disease.

[3]  Yufeng Zang,et al.  Abnormal Functional Connectivity of Hippocampus During Episodic Memory Retrieval Processing Network in Amnestic Mild Cognitive Impairment , 2009, Biological Psychiatry.

[4]  Kristina D. Micheva,et al.  Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.

[5]  Brian M. Barnes,et al.  PHF-like tau phosphorylation in mammalian hibernation is not associated with p25-formation , 2009, Journal of Neural Transmission.

[6]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[7]  A. Kenworthy,et al.  Lipid rafts, cholesterol, and the brain , 2008, Neuropharmacology.

[8]  D. Selkoe,et al.  Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.

[9]  M. Rowan,et al.  Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo. , 2008, Brain : a journal of neurology.

[10]  Daniel L. Rubin,et al.  Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease , 2008, PLoS Comput. Biol..

[11]  G. Muntané,et al.  Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies , 2008, Neuroscience.

[12]  F. Fahrenholz,et al.  ADAM-10 over-expression increases cortical synaptogenesis , 2008, Neurobiology of Aging.

[13]  O. Arancio,et al.  Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction , 2008, The Journal of Neuroscience.

[14]  N. Inestrosa,et al.  β-Amyloid Oligomers Affect the Structure and Function of the Postsynaptic Region: Role of the Wnt Signaling Pathway , 2008, Neurodegenerative Diseases.

[15]  C. Aoki,et al.  Chemical and morphological alterations of spines within the hippocampus and entorhinal cortex precede the onset of Alzheimer's disease pathology in double knock‐in mice , 2007, The Journal of comparative neurology.

[16]  V. Calhoun,et al.  Selective changes of resting-state networks in individuals at risk for Alzheimer's disease , 2007, Proceedings of the National Academy of Sciences.

[17]  R. Anwyl,et al.  Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. , 2007, Biochemical Society transactions.

[18]  D. Bennett,et al.  Paradoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment , 2007, The Journal of Neuroscience.

[19]  T. Arendt,et al.  Erratum to “Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity” [Biochim. Biophys. Acta 1772 (2007) 413–421] , 2007 .

[20]  T. Arendt,et al.  Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons. , 2007, Cerebral cortex.

[21]  J. Hanoune.  Handbook of Neurochemistry and Molecular Neurobiology: Behavioral Neurochemistry, Neuroendocrinology and Molecular Neurobiology , 2007 .

[22]  O. Arancio,et al.  Neurotrophins, synaptic plasticity and dementia , 2007, Current Opinion in Neurobiology.

[23]  A. Delacourte,et al.  Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity , 2007, Proceedings of the National Academy of Sciences.

[24]  F. Schmitt,et al.  Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.

[25]  S. Ferreira,et al.  Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts , 2007, Progress in Neurobiology.

[26]  T. Arendt,et al.  Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity. , 2007, Biochimica et biophysica acta.

[27]  B. Kalisch,et al.  Nitric oxide synthase inhibitors modulate nerve growth factor‐mediated regulation of amyloid precursor protein expression in PC12 cells , 2007, Journal of neurochemistry.

[28]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[29]  R. Sperling,et al.  Functional MRI Studies of Associative Encoding in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[30]  Craig C Garner,et al.  Synaptic Protein Dynamics in Hibernation , 2007, The Journal of Neuroscience.

[31]  T. Arendt,et al.  Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons – implications for Alzheimer's disease , 2007, The European journal of neuroscience.

[32]  Bruce S. McEwen,et al.  Rapid and reversible changes in intrahippocampal connectivity during the course of hibernation in European hamsters , 2006, Proceedings of the National Academy of Sciences.

[33]  G. E. Alexander,et al.  Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment , 2006, Neurobiology of Aging.

[34]  F. Schmitt,et al.  Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment , 2006, Neurobiology of Aging.

[35]  J. Götz,et al.  Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? , 2006, Journal of neurochemistry.

[36]  T. Bliss,et al.  Plasticity in the human central nervous system. , 2006, Brain : a journal of neurology.

[37]  R. Vink,et al.  Soluble amyloid precursor protein α reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats , 2006, Brain Research.

[38]  J. Wuu,et al.  Differential Expression of Synaptic Proteins in the Frontal and Temporal Cortex of Elderly Subjects With Mild Cognitive Impairment , 2006, Journal of neuropathology and experimental neurology.

[39]  Tianzi Jiang,et al.  Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI , 2006, NeuroImage.

[40]  U. Müller,et al.  Lengthening of G2/mitosis in cortical precursors from mice lacking β-amyloid precursor protein , 2005, Neuroscience.

[41]  Bassem A. Hassan,et al.  Amyloid precursor protein promotes post‐developmental neurite arborization in the Drosophila brain , 2005, The EMBO journal.

[42]  L. Reichardt,et al.  The origin recognition core complex regulates dendrite and spine development in postmitotic neurons , 2005, The Journal of cell biology.

[43]  W. Gan,et al.  Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2 , 2005, Neuroscience Letters.

[44]  W. K. Cullen,et al.  Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.

[45]  M. Chao,et al.  Cleavage of p75 Neurotrophin Receptor by α-Secretase and γ-Secretase Requires Specific Receptor Domains* , 2005, Journal of Biological Chemistry.

[46]  W. Gan,et al.  Defective Neuromuscular Synapses in Mice Lacking Amyloid Precursor Protein (APP) and APP-Like Protein 2 , 2005, The Journal of Neuroscience.

[47]  T. Arendt,et al.  Expression of cell cycle-related proteins in developing and adult mouse hippocampus , 2005, International Journal of Developmental Neuroscience.

[48]  Jochen Herms,et al.  Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members , 2004 .

[49]  Dominic M. Walsh,et al.  Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.

[50]  T. Mittmann,et al.  Neuronal activation of Ras regulates synaptic connectivity , 2004, The European journal of neuroscience.

[51]  W. K. Cullen,et al.  Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo , 2004, The European journal of neuroscience.

[52]  Alexander Bain,et al.  Mind and body: The theories of their relation , 2004 .

[53]  Á. Pascual,et al.  Regulation of β‐amyloid precursor protein expression by brain‐derived neurotrophic factor involves activation of both the Ras and phosphatidylinositide 3‐kinase signalling pathways , 2004, Journal of neurochemistry.

[54]  Christian Humpel,et al.  Chromogranin peptides in Alzheimer's disease , 2004, Experimental Gerontology.

[55]  W. Honer.  Pathology of presynaptic proteins in Alzheimer’s disease: more than simple loss of terminals , 2003, Neurobiology of Aging.

[56]  P. Coleman,et al.  Synaptic slaughter in Alzheimer’s disease , 2003, Neurobiology of Aging.

[57]  T. Arendt.  Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the ‘Dr. Jekyll and Mr. Hyde concept’ of Alzheimer’s disease or the yin and yang of neuroplasticity , 2003, Progress in Neurobiology.

[58]  Wolfgang Härtig,et al.  Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating Animals , 2003, The Journal of Neuroscience.

[59]  P. Greengard,et al.  The Amyloid Precursor Protein and Its Regulatory Protein, FE65, in Growth Cones and Synapses In Vitro and In Vivo , 2003, The Journal of Neuroscience.

[60]  C. Peers,et al.  The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons , 2003, The Journal of Neuroscience.

[61]  E. Zee,et al.  Hippocampal synaptophysin immunoreactivity is reduced during natural hypothermia in ground squirrels , 2003, Neuroscience Letters.

[62]  P. Coleman,et al.  Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease , 2003, Neurobiology of Disease.

[63]  B. Hyman,et al.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. , 2002, Archives of neurology.

[64]  Henrik Adam,et al.  The whole is more than the sum of its parts , 2002, ATZautotechnology.

[65]  P. Coleman,et al.  Progressive Reduction of Synaptophysin Message in Single Neurons in Alzheimer Disease , 2002, Journal of neuropathology and experimental neurology.

[66]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[67]  C. Humpel,et al.  Synaptic proteins in Alzheimer’s disease , 2002, Journal of Molecular Neuroscience.

[68]  B. Lanier.  When the whole is more than the sum of its parts. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[69]  L. Goldstein,et al.  Disruption of Axonal Transport and Neuronal Viability by Amyloid Precursor Protein Mutations in Drosophila , 2001, Neuron.

[70]  W. Honer,et al.  Synaptic Pathology in Prefrontal Cortex is Present Only with Severe Dementia in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[71]  G. Collingridge,et al.  Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein , 2001, The Journal of Neuroscience.

[72]  Martin Fieder,et al.  Hibernation Effects on Memory in European Ground Squirrels (Spermophilus citellus) , 2001, Journal of biological rhythms.

[73]  V. Bigl,et al.  Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo , 2001, International Journal of Developmental Neuroscience.

[74]  Á. Pascual,et al.  Nerve growth factor modulates the expression and secretion of β‐amyloid precursor protein through different mechanisms in PC12 cells , 2001, Journal of neurochemistry.

[75]  E. Zenteno,et al.  O‐Glycosylation in Sprouting Neurons in Alzheimer Disease, Indicating Reactive Plasticity , 2001, Journal of neuropathology and experimental neurology.

[76]  T. Arendt.  Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization , 2001, Neuroscience.

[77]  E. Masliah,et al.  Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease , 2001, Neurology.

[78]  D. Featherstone,et al.  Surprises from Drosophila: genetic mechanisms of synaptic development and plasticity , 2000, Brain Research Bulletin.

[79]  H. Lipp,et al.  Mice with Combined Gene Knock-Outs Reveal Essential and Partially Redundant Functions of Amyloid Precursor Protein Family Members , 2000, The Journal of Neuroscience.

[80]  S. Henriksen,et al.  In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice , 2000, Brain Research.

[81]  K. Jellinger,et al.  Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer’s disease , 2000, Acta Neuropathologica.

[82]  E B Mukaetova-Ladinska,et al.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. , 2000, The American journal of pathology.

[83]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[84]  L. Martin,et al.  Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains , 2000, Journal of the Neurological Sciences.

[85]  Stanley I. Rapoport,et al.  In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer’s disease , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[86]  V. Budnik,et al.  The Drosophila β-Amyloid Precursor Protein Homolog Promotes Synapse Differentiation at the Neuromuscular Junction , 1999, The Journal of Neuroscience.

[87]  L. M. Callahan,et al.  Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry , 1999, Neuroscience.

[88]  L. Firestone,et al.  Platelet membrane fluidity individuals at risk for Alzheimer’s disease: a comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy , 1999, Psychopharmacology.

[89]  H. Lipp,et al.  No hippocampal neuron or synaptic bouton loss in learning-impaired aged β-Amyloid precursor protein-null mice , 1999, Neuroscience.

[90]  T. Shirao,et al.  Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[91]  U. Gärtner,et al.  Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration , 1999, Neuroscience.

[92]  C. Oliveira,et al.  Effects of apolipoprotein E genotype on blood lipid composition and membrane platelet fluidity in Alzheimer's disease. , 1999, Biochimica et biophysica acta.

[93]  T. Tully,et al.  latheo, a Drosophila Gene Involved in Learning, Regulates Functional Synaptic Plasticity , 1999, Neuron.

[94]  T. Tully,et al.  latheo Encodes a Subunit of the Origin Recognition Complex and Disrupts Neuronal Proliferation and Adult Olfactory Memory When Mutant , 1999, Neuron.

[95]  Hilkka Soininen,et al.  Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation , 1999, The European journal of neuroscience.

[96]  H. Lipp,et al.  Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[97]  G. Collingridge,et al.  Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein , 1999, Neuropharmacology.

[98]  P. Coleman,et al.  Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. , 1999, Journal of neuropathology and experimental neurology.

[99]  T. Bliss,et al.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice , 1999, Nature Neuroscience.

[100]  G. Dawson,et al.  Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein , 1999, Neuroscience.

[101]  Steffen Roßner,et al.  The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling , 1998, Progress in Neurobiology.

[102]  H. Meziane,et al.  Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[103]  T. Shirao,et al.  Differential expression of rat brain synaptic proteins in development and aging. , 1998, Biochemical and biophysical research communications.

[104]  E. Bigio,et al.  Neocortical Synapse Density and Braak Stage in the Lewy Body Variant of Alzheimer Disease: A Comparison with Classic Alzheimer Disease and Normal Aging , 1998, Journal of neuropathology and experimental neurology.

[105]  J. Perez-polo,et al.  p75 and TrkA Receptor Signaling Independently Regulate Amyloid Precursor Protein mRNA Expression, Isoform Composition, and Protein Secretion in PC12 Cells , 1998, Journal of neurochemistry.

[106]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[107]  A. Gabriel,et al.  Rapid temperature changes induce adenosine-mediated depression of synaptic transmission in hippocampal slices from rats (non-hibernators) but not in slices from golden hamsters (hibernators) , 1998, Neuroscience.

[108]  S. Love,et al.  Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer’s disease and dementia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[109]  Paul J. Harrison,et al.  Temporal Cortex Synaptophysin mRNA Is Reduced in Alzheimer's Disease and Is Negatively Correlated with the Severity of Dementia , 1998, Experimental Neurology.

[110]  H. Hinterhuber,et al.  Synaptic loss reflected by secretoneurin‐like immunoreactivity in the human hippocampus in Alzheimer's disease , 1998, The European journal of neuroscience.

[111]  K. Blennow,et al.  Neurochemical Dissection of Synaptic Pathology in Alzheimer's Disease , 1998, International Psychogeriatrics.

[112]  C. Duyckaerts,et al.  Accumulation of SNAP‐25 immunoreactive material in axons of Alzheimer's disease , 1997, Neuroreport.

[113]  D. Price,et al.  Generation of APLP2 KO Mice and Early Postnatal Lethality in APLP2/APP Double KO Mice , 1997, Neurobiology of Aging.

[114]  Julia W. Chang,et al.  Dendritic Translocation of RC3/Neurogranin mRNA in Normal Aging, Alzheimer Disease and Fronto‐Temporal Dementia , 1997, Journal of neuropathology and experimental neurology.

[115]  D. Price,et al.  Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[116]  T. Taniguchi,et al.  Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease. , 1997, Biochemical and biophysical research communications.

[117]  Y. Bailly,et al.  Synaptic β-amyloid precursor proteins increase with learning capacity in rats , 1997, Neuroscience.

[118]  M. Mattson,et al.  Secreted form of β‐amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices , 1997, Neuroreport.

[119]  K. Davis,et al.  Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. , 1997, Archives of general psychiatry.

[120]  C. Hofstetter,et al.  Dementia with Lewy Bodies Versus Pure Alzheimer Disease: Differences in Cognition, Neuropathology, Cholinergic Dysfunction, and Synapse Density , 1997, Journal of neuropathology and experimental neurology.

[121]  M. Hasselmo,et al.  A computational model of the progression of Alzheimer's disease. , 1997, M.D. computing : computers in medical practice.

[122]  J. L. Kavanau,et al.  Memory, sleep and the evolution of mechanisms of synaptic efficacy maintenance , 1997, Neuroscience.

[123]  A. Smith,et al.  Expression of cell division markers in the hippocampus in Alzheimer’s disease and other neurodegenerative conditions , 1997, Acta Neuropathologica.

[124]  S. DeKosky,et al.  Structural correlates of cognition in dementia: quantification and assessment of synapse change. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[125]  U. Gärtner,et al.  Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.

[126]  M. Mattson,et al.  Increased Activity‐Regulating and Neuroprotective Efficacy of α‐Secretase‐Derived Secreted Amyloid Precursor Protein Conferred by a C‐Terminal Heparin‐Binding Domain , 1996, Journal of neurochemistry.

[127]  L. Lue,et al.  Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. , 1996, Journal of neuropathology and experimental neurology.

[128]  C. Gottfries,et al.  Membrane Components Separate Early-Onset Alzheimer's Disease From Senile Dementia of the Alzheimer Type , 1996, International Psychogeriatrics.

[129]  Eytan Ruppin,et al.  Neuronal-Based Synaptic Compensation: A Computational Study in Alzheimer's Disease , 1996, Neural Computation.

[130]  A. Brun,et al.  Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration. , 1996, Dementia.

[131]  P. Davies,et al.  Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.

[132]  K. Blennow,et al.  Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease? , 1996, Molecular and chemical neuropathology.

[133]  A. Roses,et al.  Neurodegeneration in the Central Nervous System of apoE-Deficient Mice , 1995, Experimental Neurology.

[134]  T. Arendt,et al.  Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease , 1995, Neuroscience.

[135]  R. Heumann,et al.  Induction of p21ras in Alzheimer pathology. , 1995, Neuroreport.

[136]  H. Soininen,et al.  Alzheimer pathology of patients carrying apoliprotein E ϵ4 allele , 1995, Neurobiology of Aging.

[137]  A. Brun,et al.  Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[138]  G. Dawson,et al.  β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity , 1995, Cell.

[139]  W. Honer,et al.  Correlations of synaptic and pathological markers with cognition of the elderly , 1995, Neurobiology of Aging.

[140]  D. Selkoe,et al.  Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons , 1995, The Journal of cell biology.

[141]  E. Masliah,et al.  Mechanisms of synaptic dysfunction in Alzheimer's disease. , 1995, Histology and histopathology.

[142]  H. Soininen,et al.  Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease , 1995, Neuroscience.

[143]  C. Barnes.  Normal aging: regionally specific changes in hippocampal synaptic transmission , 1994, Trends in Neurosciences.

[144]  W. Honer,et al.  Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease , 1994, Brain Research.

[145]  L. Mucke,et al.  Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice , 1994, Brain Research.

[146]  E. Masliah,et al.  Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[147]  N Butters,et al.  Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. , 1994, Archives of neurology.

[148]  M. Mattson,et al.  Secreted Forms of β‐Amyloid Precursor Protein Protect Against Ischemic Brain Injury , 1994 .

[149]  E. Masliah,et al.  Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.

[150]  F. Ruddle,et al.  Embryonic expression pattern of amyloid protein precursor suggests a role in differentiation of specific subsets of neurons. , 1994, The Journal of experimental zoology.

[151]  W. Honer,et al.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.

[152]  M. Mattson.  Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. , 1994, Journal of neurobiology.

[153]  C. Gottfries,et al.  Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) , 1994, Journal of neurochemistry.

[154]  K. Beyreuther,et al.  Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls. , 1994, Dementia.

[155]  R. Tanzi,et al.  Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). , 1994, The Journal of biological chemistry.

[156]  J Clinton,et al.  Differential synaptic loss in the cortex in Alzheimer's disease: a study using archival material. , 1994, Neuroreport.

[157]  C. Li,et al.  apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[158]  K. Jellinger,et al.  Synaptic Pathology of Alzheimer's Disease a , 1993, Annals of the New York Academy of Sciences.

[159]  K. Beyreuther,et al.  Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. , 1993, Dementia.

[160]  M. Mattson,et al.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.

[161]  E. Masliah,et al.  The Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System , 1993, Brain pathology.

[162]  E. Masliah,et al.  Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.

[163]  R. Tanzi,et al.  Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[164]  A. Shetter,et al.  Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations , 1992 .

[165]  P. Mcgeer,et al.  Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons , 1992, Brain Research.

[166]  G. Huber,et al.  β‐Amyloid Precursor Protein Isoforms in Various Rat Brain Regions and During Brain Development , 1992 .

[167]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[168]  T. Tully,et al.  latheo, a new gene involved in associative learning and memory in Drosophila melanogaster, identified from P element mutagenesis. , 1992, Genetics.

[169]  B Carragher,et al.  Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer Disease , 1992, Journal of neuropathology and experimental neurology.

[170]  C. Masters,et al.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.

[171]  W. Honer,et al.  Regional synaptic pathology in Alzheimer's disease , 1992, Neurobiology of Aging.

[172]  V. Popov,et al.  Hibernation-induced structural changes in synaptic contacts between mossy fibres and hippocampal pyramidal neurons , 1992, Neuroscience.

[173]  A. Bragin,et al.  Repeated changes of dendritic morphology in the hippocampus of ground squirrels in the course of hibernation , 1992, Neuroscience.

[174]  D. Drachman,et al.  Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses , 1992, Neurobiology of Aging.

[175]  K. Jellinger,et al.  Synaptic pathology in alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles , 1992, Neuroscience.

[176]  S. Shimohama,et al.  Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture. , 1991, Biochemical and biophysical research communications.

[177]  Walter Schubert,et al.  Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites , 1991, Brain Research.

[178]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[179]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[180]  E. Masliah,et al.  Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. , 1990, The American journal of pathology.

[181]  K. White,et al.  Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[182]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[183]  K. White,et al.  The Drosophila transcript encoded by the beta-amyloid protein precursor-like gene is restricted to the nervous system. , 1990, Development.

[184]  W. Meier-Ruge,et al.  Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease , 1990, Brain Research.

[185]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[186]  K. Jellinger,et al.  A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease , 1990, FEBS letters.

[187]  Stephen W. Scheff,et al.  Quantitative assessment of cortical synaptic density in Alzheimer's disease , 1990, Neurobiology of Aging.

[188]  D. Price,et al.  Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[189]  W. Meier-Ruge,et al.  Computer-assisted morphometry of synaptic plasticity during aging and dementia. , 1989, Pathology, research and practice.

[190]  C. Marotta,et al.  Monoclonal Antibody to Embryonic CNS Antigen A2B5 Provides Evidence for the Involvement of Membrane Components at Sites of Alzheimer Degeneration and Detects Sulfatides as Well as Gangliosides , 1989, Journal of neurochemistry.

[191]  E. Masliah,et al.  Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease , 1989, Neuroscience Letters.

[192]  K. White,et al.  A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[193]  David A. Drachman,et al.  Synaptic loss in Alzheimer's disease and other dementias , 1989, Neurology.

[194]  H. Heller,et al.  Neuronal activity during sleep and complete bouts of hibernation. , 1988, The American journal of physiology.

[195]  W. Meier-Ruge,et al.  Quantitative morphology of synaptic plasticity in the aging brain. , 1988, Scanning microscopy.

[196]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[197]  D. Mann,et al.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.

[198]  C. Grady,et al.  Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease , 1987, Brain Research.

[199]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[200]  P. Coleman,et al.  Failed Compensatory Dendritic Growth as a Pathophysiological Process in Alzheimer's Disease , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[201]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[202]  T. Arendt,et al.  Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's disease , 1985, Neuroscience.

[203]  P. Coleman,et al.  Dendritic growth in the aged human brain and failure of growth in senile dementia. , 1979, Science.

[204]  E K Perry,et al.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.

[205]  I. Evangelista,et al.  THE CONTRIBUTION OF ALTERED SYNAPSES IN THE SENILE PLAQUE: AN ELECTRON MICROSCOPIC STUDY IN ALZHEIMER'S DEMENTIA , 1967, Journal of neuropathology and experimental neurology.

[206]  A. Scheibel,et al.  Degeneration and regeneration of the nervous system , 1960 .

[207]  A. V. Gehuchten.  Anatomie du système nerveux de l'homme , 1900 .

[208]  J. Demoor,et al.  La plasticité morphologique des neurones cérébraux , 1897 .

[209]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[210]  Eric Tardif,et al.  Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. , 2008, Journal of Alzheimer's disease : JAD.

[211]  A. Strijkstra,et al.  Activity-state profile of tau kinases in hibernating animals , 2008 .

[212]  T. Arendt.  Differentiation and De-Differentiation—Neuronal Cell-Cycle Regulation During Development and Age-Related Neurodegenerative Disorders , 2008 .

[213]  G. Muntané,et al.  2.319 Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's Disease, and in Parkinson's disease and related alpha-synucleinopathies , 2007 .

[214]  P. Greengard,et al.  Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia , 2005, Journal of Neural Transmission.

[215]  K. Blennow,et al.  Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele , 2005, Journal of Neural Transmission.

[216]  M. Chao,et al.  Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. , 2005, The Journal of biological chemistry.

[217]  W. K. Cullen,et al.  Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. , 2005, Nature medicine.

[218]  J. Kaye,et al.  Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. , 2005, Journal of Alzheimer's disease : JAD.

[219]  P. Gibson.  EM study of the numbers of cortical synapses in the brains of ageing people and people with Alzheimer-type dementia , 2004, Acta Neuropathologica.

[220]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[221]  N. Cairns,et al.  Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. , 1999, Journal of neural transmission. Supplementum.

[222]  Y. Bailly,et al.  Synaptic beta-amyloid precursor proteins increase with learning capacity in rats. , 1997, Neuroscience.

[223]  W. Rosenblum.  The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. , 1997, Journal of neuropathology and experimental neurology.

[224]  T. Shirao,et al.  Disappearance of actin‐binding protein, drebrin, from hippocampal synapses in alzheimer's disease , 1996, Journal of neuroscience research.

[225]  E. Masliah,et al.  Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. , 1996, Annals of neurology.

[226]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[227]  M. Mattson,et al.  Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. , 1994, Journal of neurochemistry.

[228]  B. Hyman,et al.  Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. , 1993, Nature genetics.

[229]  D. Teplow,et al.  Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.

[230]  E. Masliah,et al.  Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. , 1991, The American journal of pathology.

[231]  Patrick R. Hof,et al.  Cellular Pathology in Alzheimer’s Disease: Implications for Corticocortical Disconnection and Differential Vulnerability , 1990 .

[232]  Gibson Ph.  EM study of the numbers of cortical synapses in the brains of ageing people and people with Alzheimer-type dementia. , 1983 .

[233]  D. D.-B.,et al.  Degeneration and Regeneration of the Nervous System , 1930, Nature.

[234]  S. R. Y. Cajal.  The Croonian lecture.—La fine structure des centres nerveux , 1894 .

[235]  Rabl-Rückhard.  Sind die Ganglienzellen amöboid? : eine Hypothese zur Mechanik psychischer Vorgänge , 1890 .